Fitness Bio Overview
- Year Founded
-
2010
- Status
-
Private
- Latest Deal Type
-
Later Stage VC
- Investors
-
2
Fitness Bio General Information
Description
Developer of Innovative and generic drug development designed to mitigate illness symptoms. The company focuses on developing and researching innovative drug in areas include connective tissue diseases and cerebrovascular diseases, providing advanced medical solution for patients.
Contact Information
Website
www.fitnessbio.cnCorporate Office
- No. 319, Xiangjiang Road, Shijiazhuang High-tech Zone
- 6-501
- Shijiazhuang, Hebei 050035
- China
Corporate Office
- No. 319, Xiangjiang Road, Shijiazhuang High-tech Zone
- 6-501
- Shijiazhuang, Hebei 050035
- China
Fitness Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC | 07-Jul-2023 | Completed | Generating Revenue | |||
| 1. Later Stage VC | 28-Jan-2022 | Completed | Generating Revenue |
Fitness Bio Patents
Fitness Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2026062990-A | Use of se-dr affinitive peptides for the preparation of a medicament for treating rheumatic diseases | Pending | 30-Jul-2021 | ||
| EP-4378471-A1 | Use of se-dr affinity peptide in preparing drug for treating rheumatic disease | Pending | 30-Jul-2021 | ||
| EP-4378471-A4 | Use of se-dr affinity peptide in preparing drug for treating rheumatic disease | Pending | 30-Jul-2021 | ||
| US-20250074946-A1 | Use of se-dr affinity peptide in preparing drug for treating rheumatic disease | Pending | 30-Jul-2021 | ||
| WO-2023006125-A1 | Use of se-dr affinity peptide in preparing drug for treating rheumatic disease | Inactive | 30-Jul-2021 | C07K14/001 |
Fitness Bio Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Shanghai Junquanxin Investment | Venture Capital | Minority | ||
| Chiron Ventures | Venture Capital | Minority |
Fitness Bio FAQs
-
When was Fitness Bio founded?
Fitness Bio was founded in 2010.
-
Where is Fitness Bio headquartered?
Fitness Bio is headquartered in Shijiazhuang, China.
-
What industry is Fitness Bio in?
Fitness Bio’s primary industry is Drug Discovery.
-
Is Fitness Bio a private or public company?
Fitness Bio is a Private company.
-
What is Fitness Bio’s current revenue?
The current revenue for Fitness Bio is .
-
Who are Fitness Bio’s investors?
Shanghai Junquanxin Investment and Chiron Ventures have invested in Fitness Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process